AI
Friday, December 08, 2017 8:01:04 AM
I agree on all points. Here is a story that shows they are also paying to stop legalization in States.
https://www.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona
According to this recent article they are also having difficulties with Biosynthesis.
The primary restrictive factor is the difficulty of duplicating these compounds in a way that makes them identical to the naturally-occurring ones.
https://www.prnewswire.com/news-releases/biosynthesis-making-the-impossible-possible-in-medicinal-cannabis-657441003.html
Various companies have attempted to chemically synthesize cannabinoid compounds for pharmaceutical application, but the primary restrictive factor is the difficulty of duplicating these compounds in a way that makes them identical to the naturally-occurring ones.
https://www.theguardian.com/us-news/2017/apr/03/big-pharma-marijuana-competition-insys-arizona
According to this recent article they are also having difficulties with Biosynthesis.
The primary restrictive factor is the difficulty of duplicating these compounds in a way that makes them identical to the naturally-occurring ones.
https://www.prnewswire.com/news-releases/biosynthesis-making-the-impossible-possible-in-medicinal-cannabis-657441003.html
Various companies have attempted to chemically synthesize cannabinoid compounds for pharmaceutical application, but the primary restrictive factor is the difficulty of duplicating these compounds in a way that makes them identical to the naturally-occurring ones.
The truth is incontrovertible. Malice may attack it,
ignorance may deride it, but in the end, there it is.
Do Your Own DD Do not take my investing advice.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
